Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: What are the risks of waiting?

BACKGROUND: Clinical trials have confirmed that implantable cardioverter defibrillators (ICDs) reduce mortality in patients with a left ventricular ejection fraction below 30%. The ‘real-world’ prognosis before ICD implantation in such patients is not known. The estimated risk of death is 0.8% per m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ghosh, Nina, Mangat, Iqwal, O’Donnell, Suzan S, Pinter, Arnold, Korley, Victoria, Lane, Chris, Dorian, Paul
Format: Artigo
Idioma:Inglês
Publicat: Pulsus Group Inc 2009
Matèries:
Clinical Studies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2782507/
https://ncbi.nlm.nih.gov/pubmed/19812807
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars